Dividends & Income
To screen ETFs by asset class, performance, yield and more, check out the
View as an RSS Feed
) can't catch a break. Shares are diving yet again after a
(.pdf) from Chief Scientific Officer David Young at a JMP conference
failed to soothe fears
stoked by a brutal Citron Research
on Tuesday. While discussing how Questcor's Acthar gel is differentiated, Young's review of the history of generic/third-party alternatives (page 11) may have done more harm than good. Questcor is
from Monday's close.
View news story
Questor is in a quiet period due to upcoming quarterly report. It is not surprising that Questor is making no comment since the negative comment are self-serving and the answer will be the quarterly report coming out July 24th. Any comment would only give credence to the negatives and start a debate that means nothing at this point.
Jul 14, 2012. 05:47 AM
Link to Comment
Xignite quote data
© 2015 Seeking Alpha